What should hospital procurement teams weigh most when comparing closure-device vendors?

Deployment consistency across operators matters more than unit price alone. Vendors with documented complication-rate data across diverse access sizes typically win multi-year contracts [9]. Read More

How do bioabsorbable and permanent-implant closure devices differ in practice?

Bioabsorbable devices dissolve over weeks, reducing concerns about repeat-access interference. Permanent implants offer faster deployment but carry long-term foreign-material considerations [4]. Read More

Is device-based closure replacing manual compression entirely?

No. Manual compression remains common for low-acuity diagnostic cases, especially in cost-constrained settings. Device-based closure concentrates in large-bore and high-volume procedural environments [8]. Read More

What regulatory nuance affects new closure-material launches in Europe?

EU MDR conformity reassessment has extended approval timelines for implantable materials. Manufacturers now budget longer commercialization windows for collagen and polymer-based products [12]. Read More

Are there integration challenges when adopting AI-assisted closure-selection tools?

Yes — integration with existing electronic health record and cath lab imaging systems remains uneven. Hospitals piloting these tools report workflow friction during the first implementation phase. Read More

How does radial access growth affect closure-device demand?

Radial procedures use compression bands rather than implantable closure devices, so volume migration toward radial access shifts revenue toward a different product category entirely [7]. Read More

What competitive dynamic is reshaping smaller closure-device manufacturers?

Niche players like InSeal Medical are being acquired or partnered with by larger vendors seeking large-bore portfolio gaps, consolidating innovation under established distribution networks [18]. Read More

What is the current size of the vascular closure devices market?

The vascular closure devices market reached USD 1.88 billion in 2025 and is projected to reach USD 3.69 billion by 2035. Read More

What is the CAGR of the vascular closure devices market?

The vascular closure devices market is projected to grow at a CAGR of 7.05% during the forecast period 2026–2035. Read More

Which region leads the vascular closure devices market?

North America holds the largest share at 37.4%, while Asia-Pacific is the fastest-growing region at 9.6% CAGR. Read More

Vascular Closure Devices Market (2026 - 2035)

ID: MRFR/HC/4249-HCR

200 Pages

Vikita Thakur

Last Updated: July 03, 2026

Vascular Closure Devices Market Research Report: Size, Share, Trend Analysis By Device Type (Passive Closure Devices, Active Closure Devices, Suture Closure Devices, Collagen-based Closure Devices), By Procedure Type (Transvascular Procedures, Cardiac Procedures, Peripheral Procedures), By End Users (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), By Distribution Channel (Direct Sales, Online Sales, Third-party Distributors) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Vascular Closure Devices Market

Market Size

Forecast Period2026-2035

CAGR (2026-2035)7.05%

2025 Market SizeUSD 1.88 Billion

2035 Market SizeUSD 3.69 Billion

Key Players

Abbott

Terumo

Teleflex

Medtronic

Boston Scientific

Becton Dickinson

Trends

TAVR and EVAR Procedural Growth
Large-Bore Access Standardization
Outpatient and Same-Day Discharge Mandates

Opportunities

Fully Resorbable Closure Platforms
Large-Bore Systems Tied to Structural Heart Expansion
Emerging Market Cath Lab Build-Out

Summary Table of Contents Segmentation Methodology Download PDF

1 Market Overview |
1. 1.1 Study Assumptions & Market Definition |
2. 1.2 Scope of the Study |
3. 1.3 Research Methodology
2 Market Summary & Key Takeaways
3 Market Dynamics |
1. 3.1 Market Drivers Analysis | |
  1. 3.1.1 TAVR/EVAR Procedural Volume Growth | |
  2. 3.1.2 Large-Bore Access Device Adoption | |
  3. 3.1.3 Same-Day Discharge / Outpatient Mandates | |
  4. 3.1.4 Bioabsorbable Closure Material Innovation | |
  5. 3.1.5 Aging Population & Rising PAD Prevalence |
2. 3.2 Market Restraints Analysis | |
  1. 3.2.1 High Device Cost vs. Manual Compression | |
  2. 3.2.2 Vascular Complication Risk | |
  3. 3.2.3 Reimbursement Variability Across Geographies | |
  4. 3.2.4 Operator Training & Learning Curve |
3. 3.3 Market Opportunity Analysis | |
  1. 3.3.1 Fully Resorbable Closure Platforms | |
  2. 3.3.2 Large-Bore Systems for Structural Heart Expansion | |
  3. 3.3.3 Emerging Market Cath Lab Build-Out | |
  4. 3.3.4 Procedural Data & Outcomes Registries |
4. 3.4 Industry Value Chain Analysis |
5. 3.5 Porter's Five Forces Analysis
4 Vascular Closure Devices Market Size & Forecast (2021–2035) |
1. 4.1 Historical Market Size (2021–2025) |
2. 4.2 Current & Forecast Market Size (2026–2035) |
3. 4.3 Market Size by Revenue (USD Billion) |
4. 4.4 Year-over-Year Growth Analysis
5 Segmentation Analysis |
1. 5.1 By Product Type | |
  1. 5.1.1 Active Approximators | |
  2. 5.1.2 Passive Approximators |
2. 5.2 By Material Composition | |
  1. 5.2.1 Collagen-Based | |
  2. 5.2.2 PEG/Polymer-Based | |
  3. 5.2.3 Suture/Filament-Based | |
  4. 5.2.4 Other Materials |
3. 5.3 By Mode of Access | |
  1. 5.3.1 Femoral Access ≤8 Fr | |
  2. 5.3.2 Large-Bore Femoral Access ≥12 Fr | |
  3. 5.3.3 Radial Access |
4. 5.4 By Procedure Type | |
  1. 5.4.1 Interventional Cardiology | |
  2. 5.4.2 Neurovascular | |
  3. 5.4.3 Peripheral Vascular | |
  4. 5.4.4 Structural Heart/TAVR |
5. 5.5 By End User | |
  1. 5.5.1 Hospitals | |
  2. 5.5.2 Catheterization Labs / Ambulatory Surgical Centers | |
  3. 5.5.3 Outpatient Vascular Centers
6 Regional Analysis |
1. 6.1 North America | |
  1. 6.1.1 US | |
  2. 6.1.2 Canada | |
  3. 6.1.3 Mexico |
2. 6.2 Europe | |
  1. 6.2.1 Germany | |
  2. 6.2.2 UK | |
  3. 6.2.3 France | |
  4. 6.2.4 Italy | |
  5. 6.2.5 Spain | |
  6. 6.2.6 Nordic Countries | |
  7. 6.2.7 Russia | |
  8. 6.2.8 Rest of Europe |
3. 6.3 Asia-Pacific | |
  1. 6.3.1 China | |
  2. 6.3.2 India | |
  3. 6.3.3 Japan | |
  4. 6.3.4 South Korea | |
  5. 6.3.5 ASEAN | |
  6. 6.3.6 Rest of Asia-Pacific |
4. 6.4 South America | |
  1. 6.4.1 Brazil | |
  2. 6.4.2 Argentina | |
  3. 6.4.3 Rest of South America |
5. 6.5 Middle East & Africa | |
  1. 6.5.1 Saudi Arabia | |
  2. 6.5.2 UAE | |
  3. 6.5.3 South Africa | |
  4. 6.5.4 Egypt | |
  5. 6.5.5 Rest of Middle East & Africa
7 Competitive Landscape |
1. 7.1 Market Share Analysis (2025) |
2. 7.2 Competitive Benchmarking Matrix |
3. 7.3 Company Profiles | |
  1. 7.3.1 Abbott | |
  2. 7.3.2 Terumo | |
  3. 7.3.3 Teleflex | |
  4. 7.3.4 Medtronic | |
  5. 7.3.5 Boston Scientific | |
  6. 7.3.6 Becton Dickinson | |
  7. 7.3.7 Cordis | |
  8. 7.3.8 Merit Medical Systems | |
  9. 7.3.9 Haemonetics (Cardiva) | |
  10. 7.3.10 InSeal Medical
8 Future Outlook & Strategic Recommendations (2026–2035) |
1. 8.1 AI-Assisted Procedural Planning |
2. 8.2 Platform Economics |
3. 8.3 Outpatient and Ambulatory Economics |
4. 8.4 ESG and Supply Chain Reporting
9 Recent Developments & News
10 Frequently Asked Questions (FAQs)
11 Report Scope & Methodology |
1. 11.1 Study Period & Base Year |
2. 11.2 Data Sources & Citations |
3. 11.3 Abbreviations
12 LIST OF TABLES |
TABLE 1 Vascular Closure Devices Market Size & Forecast, by Revenue (USD Billion), 2021–2035 |
TABLE 2 Vascular Closure Devices Market — Year-over-Year Growth Analysis, 2021–2035 |
TABLE 3 Market Size, by Product Type, 2021–2035 (USD Billion) |
TABLE 4 Market Size, by Material Composition, 2021–2035 (USD Billion) |
TABLE 5 Market Size, by Mode of Access, 2021–2035 (USD Billion) |
TABLE 6 Market Size, by Procedure Type, 2021–2035 (USD Billion) |
TABLE 7 Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 8 Market Size, by Region, 2021–2035 (USD Billion) |
TABLE 9 North America Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 10 Europe Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 11 Asia-Pacific Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 12 South America Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 13 Middle East & Africa Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 14 Driver Impact Analysis Table |
TABLE 15 Restraint Impact Analysis Table |
TABLE 16 Competitive Benchmarking Matrix |
TABLE 17 Company Profiles — Key Players |
TABLE 18 Recent Developments & Strategic Announcements, 2023–2025 |
TABLE 19 Report Scope & Methodology Summary |
TABLE 20 Detailed Sources and Citations
13 LIST OF FIGURES |
FIGURE 1 Vascular Closure Devices Market Dynamics — Drivers, Restraints, Opportunities |
FIGURE 2 Industry Value Chain Analysis |
FIGURE 3 Porter's Five Forces Analysis |
FIGURE 4 Market Size Trend, 2021–2035 (USD Billion) |
FIGURE 5 Market Share, by Product Type, 2025 |
FIGURE 6 Market Share, by Material Composition, 2025 |
FIGURE 7 Market Share, by Mode of Access, 2025 |
FIGURE 8 Market Share, by Procedure Type, 2025 |
FIGURE 9 Market Share, by End User, 2025 |
FIGURE 10 Regional Market Share, 2025 |
FIGURE 11 Competitive Landscape — Revenue Share Estimates, 2025

Certified Researchers

Customize Report

Segmentation Quick Reference

Dimension	Sub-Segments	Dominant Segment	Fastest Growing Segment
Product Type	Active Approximators, Passive Approximators	Active Approximators	Passive Approximators
Material Composition	Collagen-Based, PEG/Polymer-Based, Suture/Filament-Based, Other	Collagen-Based	Suture/Filament-Based
Mode of Access	Femoral ≤8 Fr, Femoral ≥12 Fr, Radial	Femoral ≤8 Fr	Femoral ≥12 Fr
Procedure Type	Interventional Cardiology, Neurovascular, Peripheral Vascular, Structural Heart/TAVR	Interventional Cardiology	Neurovascular
End User	Hospitals, Cath Labs/ASCs, Outpatient Vascular Centers	Hospitals	Cath Labs/ASCs

Market Segmentation Overview

By Product Type

Sub-Segment	Key Trend
Active Approximators	Continued preference in high-volume cath labs
Passive Approximators	Rising bioabsorbable formulation adoption

Active approximator systems remain the clinical workhorse across most procedural settings, while passive approximator platforms are steadily gaining share as resorption profiles improve.

By Material Composition

Sub-Segment	Key Trend
Collagen-Based	Largest installed clinical base
PEG/Polymer-Based	Niche growth in specialty centers
Suture/Filament-Based	Fastest-growing material category
Other Vascular Closure Devices Market	Limited but stable niche use

Collagen-based systems retain the broadest clinical familiarity, but suture and filament-based platforms are scaling quickly among operators managing repeat-access patients.

By Mode of Access

Sub-Segment	Key Trend
Femoral ≤8 Fr	Stable diagnostic-procedure demand
Femoral ≥12 Fr	Growth tied to structural heart volume
Radial	Compression-band innovation is expanding its use.

Large-bore femoral access is the structural growth engine of the category, closely tracking TAVR and EVAR case volumes.

By Procedure Type

Sub-Segment	Key Trend
Interventional Cardiology	Largest base, steady growth
Neurovascular	Fastest-growing procedural category
Peripheral Vascular	Growth tied to PAD prevalence
Structural Heart/TAVR	Expanding indication set

Neurovascular procedures are scaling quickly as stroke-center networks expand mechanical thrombectomy capability, pulling closure-device demand into a historically smaller procedural category.

By End User

Sub-Segment	Key Trend
Hospitals	Continued dominance for complex cases
Catheterization Labs / ASCs	Fastest-growing setting
Outpatient Vascular Centers	Rising share tied to same-day discharge

Ambulatory surgical centers and standalone catheterization labs are absorbing a growing share of lower-acuity procedural volume as outpatient reimbursement broadens.

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”